Cargando…
Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus
The prevalence of obesity and metabolic syndrome increases in patients with type 1 diabetes mellitus (T1DM). In the general population this is linked with ectopic lipid accumulation in liver (HCL) and skeletal muscle (IMCL), representing hallmarks in the development of insulin resistance. Moreover,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385341/ https://www.ncbi.nlm.nih.gov/pubmed/30796305 http://dx.doi.org/10.1038/s41598-019-39362-4 |
_version_ | 1783397182028644352 |
---|---|
author | Wolf, Peter Fellinger, Paul Pfleger, Lorenz Smajis, Sabina Beiglböck, Hannes Gajdošík, Martin Anderwald, Christian-Heinz Trattnig, Siegfried Luger, Anton Winhofer, Yvonne Krššák, Martin Krebs, Michael |
author_facet | Wolf, Peter Fellinger, Paul Pfleger, Lorenz Smajis, Sabina Beiglböck, Hannes Gajdošík, Martin Anderwald, Christian-Heinz Trattnig, Siegfried Luger, Anton Winhofer, Yvonne Krššák, Martin Krebs, Michael |
author_sort | Wolf, Peter |
collection | PubMed |
description | The prevalence of obesity and metabolic syndrome increases in patients with type 1 diabetes mellitus (T1DM). In the general population this is linked with ectopic lipid accumulation in liver (HCL) and skeletal muscle (IMCL), representing hallmarks in the development of insulin resistance. Moreover, hepatic mitochondrial activity is lower in newly diagnosed patients with T1DM. If this precedes later development of diabetes related fatty liver disease is currently not known. This study aims to investigate energy metabolism in liver (k(ATP)) and skeletal muscle (k(CK)) and its impact on HCL, IMCL, cardiac fat depots and heart function in 10 patients with long standing T1DM compared to 11 well-matched controls by (31)P/(1)H magnetic resonance spectroscopy. HCL was almost 70% lower in T1DM compared to controls (6.9 ± 5% vs 2.1 ± 1.3%; p = 0.030). Also k(ATP) was significantly reduced (0.33 ± 0.1 s(−1) vs 0.17 ± 0.1 s(−1); p = 0.018). In T1DM, dose of basal insulin strongly correlated with BMI (r = 0.676, p = 0.032) and HCL (r = 0.643, p = 0.045), but not with k(ATP). In the whole cohort, HCL was significantly associated with BMI (r = 0.615, p = 0.005). In skeletal muscle k(CK) was lower in patients with T1DM (0.25 ± 0.05 s(−1) vs 0.31 ± 0–04 s(−1); p = 0.039). No significant differences were found in IMCL. Cardiac fat depots as well as heart function were not different. Our results in patients with long standing T1DM show that HCL is lower compared to matched controls, despite reduced energy metabolism in liver and skeletal muscle. |
format | Online Article Text |
id | pubmed-6385341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63853412019-02-27 Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus Wolf, Peter Fellinger, Paul Pfleger, Lorenz Smajis, Sabina Beiglböck, Hannes Gajdošík, Martin Anderwald, Christian-Heinz Trattnig, Siegfried Luger, Anton Winhofer, Yvonne Krššák, Martin Krebs, Michael Sci Rep Article The prevalence of obesity and metabolic syndrome increases in patients with type 1 diabetes mellitus (T1DM). In the general population this is linked with ectopic lipid accumulation in liver (HCL) and skeletal muscle (IMCL), representing hallmarks in the development of insulin resistance. Moreover, hepatic mitochondrial activity is lower in newly diagnosed patients with T1DM. If this precedes later development of diabetes related fatty liver disease is currently not known. This study aims to investigate energy metabolism in liver (k(ATP)) and skeletal muscle (k(CK)) and its impact on HCL, IMCL, cardiac fat depots and heart function in 10 patients with long standing T1DM compared to 11 well-matched controls by (31)P/(1)H magnetic resonance spectroscopy. HCL was almost 70% lower in T1DM compared to controls (6.9 ± 5% vs 2.1 ± 1.3%; p = 0.030). Also k(ATP) was significantly reduced (0.33 ± 0.1 s(−1) vs 0.17 ± 0.1 s(−1); p = 0.018). In T1DM, dose of basal insulin strongly correlated with BMI (r = 0.676, p = 0.032) and HCL (r = 0.643, p = 0.045), but not with k(ATP). In the whole cohort, HCL was significantly associated with BMI (r = 0.615, p = 0.005). In skeletal muscle k(CK) was lower in patients with T1DM (0.25 ± 0.05 s(−1) vs 0.31 ± 0–04 s(−1); p = 0.039). No significant differences were found in IMCL. Cardiac fat depots as well as heart function were not different. Our results in patients with long standing T1DM show that HCL is lower compared to matched controls, despite reduced energy metabolism in liver and skeletal muscle. Nature Publishing Group UK 2019-02-22 /pmc/articles/PMC6385341/ /pubmed/30796305 http://dx.doi.org/10.1038/s41598-019-39362-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Wolf, Peter Fellinger, Paul Pfleger, Lorenz Smajis, Sabina Beiglböck, Hannes Gajdošík, Martin Anderwald, Christian-Heinz Trattnig, Siegfried Luger, Anton Winhofer, Yvonne Krššák, Martin Krebs, Michael Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
title | Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
title_full | Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
title_fullStr | Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
title_full_unstemmed | Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
title_short | Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
title_sort | reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385341/ https://www.ncbi.nlm.nih.gov/pubmed/30796305 http://dx.doi.org/10.1038/s41598-019-39362-4 |
work_keys_str_mv | AT wolfpeter reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT fellingerpaul reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT pflegerlorenz reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT smajissabina reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT beiglbockhannes reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT gajdosikmartin reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT anderwaldchristianheinz reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT trattnigsiegfried reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT lugeranton reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT winhoferyvonne reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT krssakmartin reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus AT krebsmichael reducedhepatocellularlipidaccumulationandenergymetabolisminpatientswithlongstandingtype1diabetesmellitus |